Incidence of Fanconi anaemia in phenotypically normal aplastic anaemia patients in West Bengal

ABSTRACT Objectives: Fanconi anaemia (FA) is a rare inherited bone marrow failure and autosomal recessive blood disorder. FA patients have a higher risk of cancer, including acute myeloid leukaemia and squamous cell carcinoma. Maximum, but not all, affected individuals have one or more somatic abnormalities, including skin, skeletal, genitourinary, gastrointestinal, cardiac and neurological anomalies, etc. Positive stress cytogenetics has immense implications for the treatment and management of FA. The aim of our study was to find out the incidence of FA in the population of phenotypically normal aplastic anaemia (AA) patients in West Bengal. Methods: Ethical clearances were obtained from the corresponding institutional committees. A total of 117 AA cases was selected. Stress cytogenetics was performed from peripheral venous blood (PVB) samples of 63 AA patients (age ≤ 50 years) and 63 age- and sex-matched healthy individual (control) using Mitomycin C (MMC). Results: Out of 63 AA patients, 6 (9.25%) cases showed positive stress cytogenetics suggestive of FA, which is statistically significant (p-value – 0.000532), analysed by chi-square test. Discussion: A considerable percentage of patients showing sensitivity towards MMC, even if they are phenotypically normal and did not have any distinguishable features which are generally found in FA. Conclusion: This observation may indicate that stress cytogenetics analysis of phenotypically normal AA patients (≤50 years) is essential for the improvement of the treatment procedure.

[1]  A. Aziz,et al.  Fanconi Anaemia – A Rare Case Report , 2017 .

[2]  Z. Shah,et al.  Clastogen-Induced Chromosomal Breakage Analysis of Suspected Fanconis Anemia Cases of Kashmir, North India , 2016 .

[3]  D. Galloway,et al.  Skin and Mucosal Human Papillomavirus Seroprevalence in Persons with Fanconi Anemia , 2015, Clinical and Vaccine Immunology.

[4]  A. Auerbach Diagnosis of Fanconi Anemia by Diepoxybutane Analysis , 2003, Current protocols in human genetics.

[5]  S. Olson Fanconi Anemia : Guidelines for Diagnosis and Management 28 Test 1 : Chromosome Breakage in Peripheral Blood Lymphocytes , 2015 .

[6]  B. Kumar,et al.  Clinicohaematological profile of aplastic anaemia in BRIMS, Teaching Hospital, Bidar , 2014 .

[7]  M. Kumar,et al.  Clinicohematological correlation and chromosomal breakage analysis in suspected Fanconi anemia patients of India , 2014, Indian Journal of Medical and Paediatric Oncology.

[8]  Z. Zubaidah,et al.  CHROMOSOMAL BREAKAGE TEST IN THE DIAGNOSIS OF FANCONI ANEMA IN PATIENTS WITH APLASTIC ANEMIA , 2014 .

[9]  I. Chakrabarti,et al.  Fanconi Anemia with Incidental Haemoglobin E Trait: The First Reported Case in Literature , 2014, Indian Journal of Hematology and Blood Transfusion.

[10]  M. Bhargava,et al.  Fanconi anemia presenting as an “evolving” acute leukemia-diagnostic challenges , 2013, Indian Journal of Medical and Paediatric Oncology.

[11]  H. Joenje,et al.  Diagnosis of Fanconi Anemia: Chromosomal Breakage Analysis , 2012, Anemia.

[12]  K. Ghosh,et al.  Current and emerging therapeutic strategies for Fanconi anemia , 2012, The HUGO Journal.

[13]  N. Ilić,et al.  Diagnosis of Fanconi’s Anemia by Diepoxybutane Analysis in Children from Serbia , 2011, Balkan journal of medical genetics : BJMG.

[14]  Rafael Fabiano Machado Rosa,et al.  Características clínicas de pacientes com anemia de Fanconi , 2011 .

[15]  P. Rosenberg,et al.  How high are carrier frequencies of rare recessive syndromes? Contemporary estimates for Fanconi Anemia in the United States and Israel , 2011, American journal of medical genetics. Part A.

[16]  R. Rosa,et al.  Clinical characteristics of patients with Fanconi anemia , 2011 .

[17]  A. D’Andrea,et al.  Expanded roles of the Fanconi anemia pathway in preserving genomic stability. , 2010, Genes & development.

[18]  K. Ghosh,et al.  Clinical, genetic and cytogenetic study of Fanconi anemia in an Indian population , 2010, Hematology.

[19]  N. Tyagi,et al.  Chromosomal Breakage Study in Aplastic Anemia Patients in India , 2010 .

[20]  P. Rosenberg,et al.  Cancer in dyskeratosis congenita. , 2009, Blood.

[21]  J. Soulier,et al.  Diagnosis of Fanconi anemia in patients with bone marrow failure , 2009, Haematologica.

[22]  T. Vulliamy,et al.  Inherited aplastic anaemias/bone marrow failure syndromes. , 2008, Blood reviews.

[23]  B. Bhatia,et al.  A study of bone marrow failure syndrome in children. , 2008, Indian journal of medical sciences.

[24]  T. Taniguchi,et al.  The Fanconi anemia pathway and ubiquitin , 2007, BMC Biochemistry.

[25]  Hans Joenje,et al.  Fanconi anemia and DNA replication repair. , 2007, DNA repair.

[26]  A. Manoharan Fanconi anaemia , 2006, British journal of haematology.

[27]  R. Marwaha,et al.  Multiple constitutional aetiological factors in bone marrow failure syndrome (BMFS) patients from north India. , 2006, The Indian journal of medical research.

[28]  A. Carnevale,et al.  DEB test for Fanconi anemia detection in patients with atypical phenotypes , 2004, American journal of medical genetics. Part A.

[29]  M. S. Ilúrdoz,et al.  Anemia de Fanconi: Consideraciones actuales , 2003 .

[30]  A. D’Andrea,et al.  A novel diagnostic screen for defects in the Fanconi anemia pathway. , 2002, Blood.

[31]  A. Auerbach Fanconi anemia diagnosis and the diepoxybutane (DEB) test. , 1993, Experimental hematology.

[32]  P. Kurkure,et al.  Fanconi's anemia: a clinico-hematological and cytogenetic study. , 1991, Indian Pediatrics.

[33]  R. Berger,et al.  A simple diagnostic test for Fanconi anemia by flow cytometry. , 1991, Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology.

[34]  A. Rogatko,et al.  International Fanconi Anemia Registry: relation of clinical symptoms to diepoxybutane sensitivity. , 1989, Blood.

[35]  R. Chaganti,et al.  Preliminary communication: prenatal detection of the Fanconi Anemia gene by cytogenetic methods. , 1979, American journal of human genetics.

[36]  M. Sasaki,et al.  A high susceptibility of Fanconi's anemia to chromosome breakage by DNA cross-linking agents. , 1973, Cancer research.